FCER1A and bullous pemphigoid: Human eosinophils expressing FcεRI have been recognized in sites of allergic and immune responses, including in allergen-induced late-phase cutaneous reactions [16], in the BAL of allergen-challenged atopic asthmatics [18], in allergen-induced rhinitis [17], and in bullous pemphigoid [24].